Refining the role for adult stem cells as cancer cells of origin

Trends in Cell Biology

Volumn 25, Issue 1, 2015, Pages 11-20

  White, Andrew C ^a,b   Lowry, William E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer cells of origin; Genetic hits; Stem cell niche; Tumor initiation

Indexed keywords

CRE RECOMBINASE; INTRINSIC FACTOR;

BASAL CELL CARCINOMA; CANCER STEM CELL; CARCINOGENESIS; CELL FATE; CELL POPULATION; CELL PROLIFERATION; CELL TYPE; DNA DAMAGE; GENE FREQUENCY; GENE MUTATION; HUMAN; NEOPLASM; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PROSTATE CANCER; REVIEW; SMALL INTESTINE; SOLID TUMOR; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; STEM CELL NICHE; ADULT STEM CELL; CELL TRANSFORMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL;

ADULT STEM CELLS; CARCINOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84918538918     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2014.08.008     Document Type: Review

References (154)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Visvader J.E. Cells of origin in cancer. Nature 2011, 469:314-322.
3. Blanpain C. Tracing the cellular origin of cancer. Nat. Cell Biol. 2013, 15:126-134.
4. Reya T., et al. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
5. Kreso A., Dick J.E. Evolution of the Cancer Stem Cell Model. Cell Stem Cell 2014, 14:275-291.
6. Visvader J.E., Lindeman G.J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012, 10:717-728.
7. Lowry W.E., Richter L. Signaling in adult stem cells. Front. Biosci. 2007, 12:3911-3927.
8. Nishikawa S.I., et al. Niche required for inducing quiescent stem cells. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:67-71.
9. Lowry W.E., et al. Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev. 2005, 19:1596-1611.
10. Palma V., Ruiz i Altaba A. Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex. Development 2004, 131:337-345.
11. Lim D.A., et al. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 2000, 28:713-726.
12. Quinones-Hinojosa A., et al. Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J. Comp. Neurol. 2006, 494:415-434.
13. Stingl J., et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
14. Blanpain C., Fuchs E. Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol. 2006, 22:339-373.
15. Cheshier S.H., et al. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem F cells. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:3120-3125.
16. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
17. Jaks V., et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat. Genet. 2008, 40:1291-1299.
18. Arai F., Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann. N. Y. Acad. Sci. 2007, 1106:41-53.
19. Rezza A., et al. Adult stem cell niches: cellular and molecular components. Curr. Top. Dev. Biol. 2014, 107:333-372.
20. Watt F.M., Jensen K.B. Epidermal stem cell diversity and quiescence. EMBO Mol. Med. 2009, 1:260-267.
21. Arai F., Suda T. Quiescent stem cells in the niche. StemBook 2008, Harvard Stem Cell Institute. L. Girard (Ed.).
22. Dhawan J., Rando T.A. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol. 2005, 15:666-673.
23. Diaz-Flores L., et al. Adult stem and transit-amplifying cell location. Histol. Histopathol. 2006, 21:995-1027.
24. Barker N., et al. Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell 2010, 7:656-670.
25. Stanger B.Z., et al. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 2007, 445:886-891.
26. Dor Y., et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
27. Choi T.Y., et al. Extensive conversion of hepatic biliary epithelial cells to hepatocytes after near total loss of hepatocytes in zebrafish. Gastroenterology 2014, 146:776-788.
28. Huch M., et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 2013, 494:247-250.
29. Dorrell C., et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev. 2011, 25:1193-1203.
30. Santoni-Rugiu E., et al. Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS 2005, 113:876-902.
31. Lawson D.A., et al. Isolation and functional characterization of murine prostate stem cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:181-186.
32. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 2008, 40:915-920.
33. Yan K.S., et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:466-471.
34. Van Landeghem L., et al. Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G1111-G1132.
35. Sancho E., et al. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 2004, 20:695-723.
36. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885.
37. Oshimori N., Fuchs E. Paracrine TGF-beta signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. Cell Stem Cell 2012, 10:63-75.
38. Chenn A., Walsh C.A. Increased neuronal production, enlarged forebrains and cytoarchitectural distortions in beta-catenin overexpressing transgenic mice. Cereb. Cortex 2003, 13:599-606.
39. Brzoska E., et al. Regulation of muscle stem cells activation: the role of growth factors and extracellular matrix. Vitam. Horm. 2011, 87:239-276.
40. Metzger D., et al. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:6991-6995.
41. Jackson E.L., et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001, 15:3243-3248.
42. Alcantara Llaguno S., et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009, 15:45-56.
43. Carolan P.J., Melton D.A. New findings in pancreatic and intestinal endocrine development to advance regenerative medicine. Curr. Opin. Endocrinol. Diabetes Obes. 2013, 20:1-7.
44. Alexson T.O., et al. Notch signaling is required to maintain all neural stem cell populations--irrespective of spatial or temporal niche. Dev. Neurosci. 2006, 28:34-48.
45. Fre S., et al. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005, 435:964-968.
46. Mutch C.A., et al. Beta-catenin signaling negatively regulates intermediate progenitor population numbers in the developing cortex. PLoS ONE 2010, 5:e12376.
47. Plikus M.V., et al. Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature 2008, 451:340-344.
48. Noles S.R., Chenn A. Cadherin inhibition of beta-catenin signaling regulates the proliferation and differentiation of neural precursor cells. Mol. Cell. Neurosci. 2007, 35:549-558.
49. Pinto D., Clevers H. Wnt, stem cells and cancer in the intestine. Biol. Cell 2005, 97:185-196.
50. Zechner D., et al. beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev. Biol. 2003, 258:406-418.
51. Battista D., et al. Neurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrus. Eur. J. Neurosci. 2006, 23:83-93.
52. Maroof A.M., et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013, 12:559-572.
53. Lai K., et al. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat. Neurosci. 2003, 6:21-27.
54. Makinen N., et al. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas. Int. J. Cancer 2014, 134:1008-1012.
55. Li S., Mao M. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas. Cancer Lett. 2013, 340:247-253.
56. Seshagiri S., et al. Recurrent R-spondin fusions in colon cancer. Nature 2012, 488:660-664.
57. Agrawal N., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
58. Stransky N., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
59. Nikolic A., et al. Structural and functional analysis of SMAD4 gene promoter in malignant pancreatic and colorectal tissues: detection of two novel polymorphic nucleotide repeats. Cancer Epidemiol. 2011, 35:265-271.
60. Durinck S., et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 2011, 1:137-143.
61. Sameer A.S., et al. SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene. BMC Cancer 2010, 10:300.
62. Loh K., et al. Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer 2008, 47:449-460.
63. Chan S.L., et al. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab. Invest. 2007, 87:644-650.
64. Iwai S., et al. Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2005, 131:773-782.
65. Miller S.J., et al. Mouse skin is particularly susceptible to tumor initiation during early anagen of the hair cycle: possible involvement of hair follicle stem cells. J. Invest. Dermatol. 1993, 101:591-594.
66. Lavker R.M., et al. Hair follicle stem cells: their location, role in hair cycle, and involvement in skin tumor formation. J. Invest. Dermatol. 1993, 101(1 Suppl):16S-26S.
67. Andreasen E., Borum K. The influence of the mouse hair cycle on 9, 10-dimethyl-1, 2-benzanthracene-induced skin tumors. Acta Pathol. Microbiol. Scand. Suppl. 1956, 39(Suppl 111):76-77.
68. Morris R.J., et al. Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis of infundibulum as well as in the hair follicles. Cancer Res. 2000, 60:226-229.
69. Trempus C.S., et al. CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res. 2007, 67:4173-4181.
70. Whitcomb D., Greer J. Germ-line mutations, pancreatic inflammation, and pancreatic cancer. Clin. Gastroenterol. Hepatol. 2009, 7(11 Suppl):S29-S34.
71. Ceol C.J., et al. APC and colon cancer: two hits for one. Nat. Med. 2007, 13:1286-1287.
72. Komarova N.L., Wang L. Initiation of colorectal cancer: where do the two hits hit?. Cell Cycle 2004, 3:1558-1565.
73. Quigley D.A., et al. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 2009, 458:505-508.
74. Mondal S., et al. Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells. Cancer Res. 1976, 36:2254-2260.
75. Lapouge G., et al. Identifying the cellular origin of squamous skin tumors. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7431-7436.
76. White A.C., et al. Defining the origins of Ras/p53-mediated squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7425-7430.
77. Li S., et al. A keratin 15 containing stem cell population from the hair follicle contributes to squamous papilloma development in the mouse. Mol. Carcinog. 2012, 52:751-759.
78. Donovan J. Review of the hair follicle origin hypothesis for basal cell carcinoma. Dermatol. Surg. 2009, 35:1311-1323.
79. Youssef K.K., et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nat. Cell Biol. 2010, 12:299-305.
80. Wang G.Y., et al. Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/-) mice. Cancer Cell 2011, 19:114-124.
81. Grachtchouk M., et al. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. J. Clin. Invest. 2011, 121:1768-1781.
82. Barker N., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
83. Walther V., Graham T.A. Location, location, location! The reality of life for an intestinal stem cell in the crypt. J. Pathol. 2014, 234:1-4.
84. Ritsma L., et al. Intestinal crypt homeostasis revealed at single-stem-cell level by in vivo live imaging. Nature 2014, 507:362-365.
85. Powell A.E., et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 2012, 149:146-158.
86. May R., et al. Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 2009, 27:2571-2579.
87. Zhu L., et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607.
88. Maria Cambuli F., et al. Brief report: musashi1-eGFP mice, a new tool for differential isolation of the intestinal stem cell populations. Stem Cells 2013, 31:2273-2278.
89. Munoz J., et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J. 2012, 31:3079-3091.
90. Tian H., et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011, 478:255-259.
91. Takeda N., et al. Interconversion between intestinal stem cell populations in distinct niches. Science 2011, 334:1420-1424.
92. Schepers A.G., et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
93. Simon E., et al. The spatial distribution of LGR5+ cells correlates with gastric cancer progression. PLoS ONE 2012, 7:e35486.
94. Alman B.A., et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am. J. Pathol. 1997, 151:329-334.
95. Stoyanova T., et al. Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:20111-20116.
96. Garraway I.P., et al. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 2010, 70:491-501.
97. Goldstein A.S., et al. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20882-20887.
98. Xin L., et al. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 2007, 25:2760-2769.
99. Xin L., et al. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:6942-6947.
100. Wang Z.A., et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat. Cell Biol. 2013, 15:274-283.
101. Wang X., et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009, 461:495-500.
102. Ousset M., et al. Multipotent and unipotent progenitors contribute to prostate postnatal development. Nat. Cell Biol. 2012, 14:1131-1138.
103. Goldstein A.S., et al. Identification of a cell of origin for human prostate cancer. Science 2010, 329:568-571.
104. Marusyk A., et al. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 2014, 10.1038/nature13556.
105. Driessens G., et al. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488:527-530.
106. Chen J., et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
107. Lapouge G., et al. Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness. EMBO J. 2012, 31:4563-4575.
108. Plikus M.V. New activators and inhibitors in the hair cycle clock: targeting stem cells' state of competence. J. Invest. Dermatol. 2012, 132:1321-1324.
109. Alonso L., Fuchs E. The hair cycle. J. Cell Sci. 2006, 119:391-393.
110. Paus R., Foitzik K. In search of the 'hair cycle clock': a guided tour. Differentiation 2004, 72:489-511.
111. White A.C., et al. Stem cell quiescence acts as a tumour suppressor in squamous tumours. Nat. Cell Biol. 2014, 16:99-107.
112. Paus R., et al. Chronobiology of the hair follicle: hunting the 'hair cycle clock'. J. Investig. Dermatol. Symp. Proc. 1999, 4:338-345.
113. Spencer J.M., et al. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch. Dermatol. 1995, 131:796-800.
114. Pierceall W.E., et al. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol. Carcinog. 1991, 4:196-202.
115. Corominas M., et al. ras activation in human tumors and in animal model systems. Environ. Health Perspect. 1991, 93:19-25.
116. van der Schroeff J.G., et al. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J. Invest. Dermatol. 1990, 94:423-425.
117. Blanpain C., et al. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004, 118:635-648.
118. Kimura-Ueki M., et al. Hair Cycle Resting Phase Is Regulated by Cyclic Epithelial FGF18 Signaling. J. Invest. Dermatol. 2012, 132:1338-1345.
119. Zhang J., et al. BMP signaling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion. Stem Cells 2006, 24:2826-2839.
120. Cabodi S., Taverna D. Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression?. Breast Cancer Res. 2010, 12:305.
121. Greer J.B., Whitcomb D.C. Inflammation and pancreatic cancer: an evidence-based review. Curr. Opin. Pharmacol. 2009, 9:411-418.
122. Aggarwal B.B. Inflammation, a silent killer in cancer is not so silent!. Curr. Opin. Pharmacol. 2009, 9:347-350.
123. Quante M., Wang T.C. Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology 2008, 23:350-359.
124. Kasper M., et al. Wounding enhances epidermal tumorigenesis by recruiting hair follicle keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4099-4104.
125. Mancuso M., et al. Hair cycle-dependent basal cell carcinoma tumorigenesis in Ptc1neo67/+ mice exposed to radiation. Cancer Res. 2006, 66:6606-6614.
126. Wong S.Y., Reiter J.F. From the Cover: Wounding mobilizes hair follicle stem cells to form tumors. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4093-4098.
127. Tumbar T., et al. Defining the epithelial stem cell niche in skin. Science 2004, 303:359-363.
128. Ito M., et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 2005, 11:1351-1354.
129. Gidekel Friedlander S.Y., et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 2009, 16:379-389.
130. Davidson L.A., et al. Alteration of colonic stem cell gene signatures during the regenerative response to injury. Biochim. Biophys. Acta 2012, 1822:1600-1607.
131. Westphalen C.B., et al. Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J. Clin. Invest. 2014, 124:1283-1295.
132. Schwitalla S., et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013, 152:25-38.
133. Humphries A., et al. Stem cells and inflammation in the intestine. Recent Results Cancer Res. 2011, 185:51-63.
134. Song I.Y., Balmain A. Cellular reprogramming in skin cancer. Semin. Cancer Biol. 2014, 10.1016/j.semcancer.2014.03.006.
135. Kwon O.J., et al. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E592-E600.
136. Guasch G., et al. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 2007, 12:313-327.
137. Nik A.M., et al. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling. Gastroenterology 2013, 144:1001-1011.
138. Zong Y., et al. Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E3395-E3404.
139. Memarzadeh S., et al. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 2007, 12:572-585.
140. Bhowmick N.A., et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303:848-851.
141. Snippert H.J., et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 2010, 327:1385-1389.
142. Jensen K.B., et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 2009, 4:427-439.
143. Morris R.J., et al. Capturing and profiling adult hair follicle stem cells. Nat. Biotechnol. 2004, 22:411-417.
144. Kannan K., et al. Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma. Oncotarget 2012, 3:1194-1203.
145. Sanders M.A., Valk P.J. The evolving molecular genetic landscape in acute myeloid leukaemia. Curr. Opin. Hematol. 2013, 20:79-85.
146. Donley N., Thayer M.J. DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is associated with increased genomic instability. Semin. Cancer Biol. 2013, 23:80-89.
147. Huang S., Ingber D.E. A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast Dis. 2006, 26:27-54.
148. Cancer Genome Atlas Research Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature, 489, 519-25.
149. Nakagawachi T., et al. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene 2003, 22:8835-8844.
150. Pajtler K.W., et al. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma. Acta Neuropathol. Commun. 2013, 1:19.
151. Yang L., et al. CRISPR-Cas-Mediated Targeted Genome Editing in Human Cells. Methods Mol. Biol. 2014, 1114:245-267.
152. Mali P., et al. Cas9 as a versatile tool for engineering biology. Nat. Methods 2013, 10:957-963.
153. Esvelt K.M., et al. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 2013, 10:1116-1121.
154. Mali P., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.